Unilever plc ADR Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $59.3B+9.1% YoYTTM through 31 Dec 2025
Net Income $11.1B+86.9% YoYTTM through 31 Dec 2025
Free Cash Flow $8.1BTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| EBITDA Margin | 20.5% |
| Operating Margin | 17.9% |
| Net Margin | 18.8% |
Returns
53.8%ROE
13.4%ROA
Balance Sheet Health
Current Ratio0.79x
Cash & Equivalents$3.9B
Quality Metrics
Piotroski F-Score6 / 9
FCF Margin13.7%
Rule of 4016.1
Multi-Year Trend
RevenueFY2025: $50.5B
Diluted EPSFY2025: $4.32
Dividend
$1.10Per share, FY20261.75%Yield-13.6%5-yr growth
Capital Allocation
Capex Intensity2.4%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Personal Care | $13.2B | -3.4% | View detailsFocus on winning with science-led brands across Deodorants, Skin Cleansing, and Oral Care. |
| Foods | $12.9B | -3.2% | View detailsSeparation of Foods business on track with secondary listing planned in London. |
| Beauty & Wellbeing | $12.8B | -2.3% | View detailsBuilding the future of beauty and wellbeing with premium innovations and digital commerce. |
| Home Care | $11.6B | -6.4% | View detailsSupply chain undergoing major transformation to deliver cost savings, supported by a €150 million investment across Europe. |
Financials converted at 0.8513 from EUR.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.